Subject Area | Rank | Percentile |
---|---|---|
Category: Medicine Subcategory: Surgery |
15 / 551 | |
Category: Medicine Subcategory: Oncology |
70 / 404 | |
Category: Medicine Subcategory: Cancer Research |
65 / 230 |
APC | APC Waiver | Other Charges |
---|---|---|
N/A | N/A | N/A |
Quartiles By JIF | Collection | Quartile | Rank | Percentage |
Category: OBSTETRICS & GYNECOLOGY | SCIE | Q1 | 8/136 |
|
Category: ONCOLOGY | SCIE | Q1 | 54/322 |
|
Quartiles By JCI | Collection | Quartile | Rank | Percentage |
Category: OBSTETRICS & GYNECOLOGY | SCIE | Q1 | 11/136 |
|
Category: ONCOLOGY | SCIE | Q1 | 39/322 |
|
Journal Title | h-index | CiteScore |
---|---|---|
HUMAN REPRODUCTION UPDATE | 158 | 28.80 |
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 203 | 15.90 |
FERTILITY AND STERILITY | 190 | 11.30 |
ULTRASOUND IN OBSTETRICS & GYNECOLOGY | 128 | 12.30 |
HUMAN REPRODUCTION | 209 | 10.90 |
OBSTETRICS AND GYNECOLOGY | 201 | 11.10 |
OBSTETRICAL & GYNECOLOGICAL SURVEY | 79 | 2.70 |
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 148 | 10.90 |
Gynecologic Oncology | 147 | 8.60 |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 79 | 6.60 |
Select your rating and start your review of BREAST
2024-09-04
Submission on June 7th, major revisions on August 3rd, accepted on September 4th. The editors and reviewers handled it very quickly.
2024-07-28
Please be cautious when submitting to this magazine. If you submit for external review promptly, it will be sent for review within a week. However, if you do not submit for external review, they will keep dragging it along. My submission with the editor was rejected after two months without external review, which really disappointed me.
2023-08-29
How are you now? It's been almost a month since I became an editor too
2023-03-22
Research focus: Breast cancer experience sharing - Submitted on March 15th, it has been a week and still no changes with the editor
2022-11-20
Have you received it now?
2022-09-12
Review speed: 2.0
Research focus: Breast cancer; artificial intelligence; pathology
Editorial experience sharing: Submitted on September 2nd, skipped "with editor" and went directly to "under review" on September 5th. Two reviewers accepted the review on September 8th, and it is still in this state currently
2022-09-11
Research focus: Breast cancer; Artificial Intelligence; Pathology Group Experience Sharing: Submitted on September 2nd, under review on September 5th, reviewed by two reviewers on September 8th, and there have been no changes so far
2022-08-17
The update on August 16, 2022 is still with editor
2022-08-08
2022-8-8 with editor
2022-08-04
Emphasis on Research Direction: Sharing of Clinical Trial Experience: Submission on August 5, 2022